Title |
Anti-TNF-α and hydralazine drug-induced lupus*
|
---|---|
Published in |
Anais Brasileiros de Dermatologia, January 2015
|
DOI | 10.1590/abd1806-4841.20153893 |
Pubmed ID | |
Authors |
Maria Victória Quaresma, Fred Bernardes, Fernanda Brandão de Oliveira, Mercedes Prates Pockstaller, Maria Fernanda Reis Gavazzoni Dias, David Rubem Azulay |
Abstract |
Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 4% |
Unknown | 22 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 17% |
Student > Postgraduate | 4 | 17% |
Student > Bachelor | 2 | 9% |
Other | 2 | 9% |
Student > Master | 2 | 9% |
Other | 4 | 17% |
Unknown | 5 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 39% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 9% |
Psychology | 2 | 9% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Arts and Humanities | 1 | 4% |
Other | 1 | 4% |
Unknown | 7 | 30% |